⚡️🇪🇺#CVAC #отчетность
CureVac
Revenues amounted to €41.2 million and €103.0 million for the three and twelve months ended December 31, 2021, respectively, representing an increase of €35.2 million and €54.1 million, or 587% and 111%, from €6.0 million and €48.9 million for the same periods in 2020.

⚠️🇩🇪🇪🇺#BNTX #CVAC #суд
BIONTECH LOOKING INTO TAKING LEGAL STEPS AGAINST CUREVAC -WELT

🇪🇺#CVAC #вакцина #ковид
CureVac начинает испытания антиковидной вакцины против омикрона

CureVac Starts Phase 1 Clinical Study of Modified, Omicron-Targeting COVID-19 Vaccine Candidate

💥🇪🇺#CVAC = +6%

на положительных данных по вакцинам

CureVac Announces Positive Data in Older Adults from COVID-19 and Flu mRNA Vaccine Development Programs